Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

ANSM grants authorisation for phase I/II clinical study for retinitis pigmentosa

europeanpharmaceuticalreviewOctober 12, 2017

Tag: ANSM , Retinitis

PharmaSources Customer Service